1. Home
  2. NNNN vs KOD Comparison

NNNN vs KOD Comparison

Compare NNNN & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$21.20

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Kodiak Sciences Inc

KOD

Kodiak Sciences Inc

HOLD

Current Price

$23.22

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNNN
KOD
Founded
2021
2009
Country
Germany
United States
Employees
N/A
121
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
NNNN
KOD
Price
$21.20
$23.22
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$28.29
AVG Volume (30 Days)
38.7K
503.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.60
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$446.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.91
$1.92
52 Week High
$55.65
$31.18

Technical Indicators

Market Signals
Indicator
NNNN
KOD
Relative Strength Index (RSI) 40.23 41.55
Support Level $19.25 $21.19
Resistance Level $31.44 $29.17
Average True Range (ATR) 2.40 1.70
MACD -0.19 -0.35
Stochastic Oscillator 0.33 8.59

Price Performance

Historical Comparison
NNNN
KOD

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

Share on Social Networks: